跳至主要内容
临床试验/NCT05088161
NCT05088161Unknown不适用

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年5月13日最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
Differentially expressed proteins in tumor and paracancer tissues

研究概览

简要总结

In this study, we will use high-throughput proteomics techniques to search for biomarkers of post-operative prognosis of pancreatic cancer in samples of patients who have been diagnosed with pancreatic cancer through bioinformatics analysis.

详细描述

This study plan from the affiliated hospital of Qingdao university collected 20 cases of patients with pancreatic cancer pathological tissue samples and clinical data, including clinical diagnostic information, laboratory tests, imaging examination results and other information data), through high-throughput proteomic technology in pancreatic cancer pathological finding biomarkers, the bioinformatics analysis to explore the prognosis biomarkers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients of Chinese nationality, age and gender are not limited.
  • Pathologically confirmed pancreatic cancer patients.
  • Pathological specimens were archived tumor tissue samples after a diagnosis of pancreatic cancer.
  • Clinical diagnostic information was complete three months before sampling.

排除标准

  • Patients with a second primary tumor.

结局指标

主要结局

Differentially expressed proteins in tumor and paracancer tissues

时间窗: 180 Days

Two dimensional gel electrophoresis, mass spectrometry and other techniques were used to separate and compare pancreatic cancer tissues and normal adjacent tissues to search for differentially expressed proteins.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验